[1. Long B, Brady W, Koyfman A, Gottlieb M. Cardiovascular complications in COVID-19. Am J Emerg Med. 2020;38:1504-1507. doi: 10.1016/j.ajem.2020.04.048.10.1016/j.ajem.2020.04.048]Search in Google Scholar
[2. Paramasivam A, Priyadharsini JV, Raghunandhakumar S, et al. A novel COVID-19 and its effects on cardiovascular disease. Hypertens. 2020;43:729-730. doi: 10.1038/s41440-020-0461-x.10.1038/s41440-020-0461-x]Search in Google Scholar
[3. Fried JA, Ramasubbu K, Bhatt R, et al. The variety of cardiovascular presentations of COVID-19. Circulation. 2020;141:1930-1936. doi: 10.1161/CIRCULATIONAHA.120.047164.10.1161/CIRCULATIONAHA.120.047164]Search in Google Scholar
[4. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323:1061-1069. doi: 10.1001/jama.2020.1585.10.1001/jama.2020.1585]Search in Google Scholar
[5. Zhou F, Ting Y, Ronghui D, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054-1062. doi: 10.1016/S0140-6736(20)30566-3.10.1016/S0140-6736(20)30566-3]Search in Google Scholar
[6. Huang C, Wang Y, Ren L, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506. doi: 10.1016/S0140-6736(20)30183-5.10.1016/S0140-6736(20)30183-5]Search in Google Scholar
[7. Hu H, Ma F, Wei X, Fang Y, Hongde H. Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin. Eur Heart J. 2020;ehaa190. doi: 10.1093/eurheartj/ehaa190.10.1093/eurheartj/ehaa190718434832176300]Search in Google Scholar
[8. Oudit GY, Kassiri Z, Jiang C, et al. SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Invest. 2009;39:618-625. doi: 10.1111/j.1365-2362.2009.02153.x.10.1111/j.1365-2362.2009.02153.x716376619453650]Search in Google Scholar
[9. Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17:259-260. doi: 10.1038/s41569-020-0360-5.10.1038/s41569-020-0360-5709552432139904]Search in Google Scholar
[10. Shaobo S, Qin M, Cai Y, et al. Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019. Eur Heart J. 2020;41:2070-2079. doi: 10.1093/eurheartj/ehaa408.10.1093/eurheartj/ehaa408723910032391877]Search in Google Scholar
[11. Guo T, Fan Y, Chen M, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5:1-8. doi: 10.1001/jamacardio.2020.1017.10.1001/jamacardio.2020.1017710150632219356]Search in Google Scholar
[12. Nicin L, Abplanalp W, Mellentin H, et al. CoV-2 receptor ACE2 in human hearts. Eur Heart J. 2020;41:1807-1809. doi: 10.1093/eurheartj/ehaa410.10.1093/eurheartj/ehaa410723919132383758]Search in Google Scholar
[13. Shi S, Qin M, Shen B, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5:802-810. doi: 10.1001/jamacardio.2020.0950.10.1001/jamacardio.2020.0950709784132211816]Search in Google Scholar
[14. Esfandrei M, McManus B. Molecular biology and pathogenesis of viral myocarditis. Annu Rev Pathol. 2008;3:127-155. doi: 10.1146/annurev.pathmechdis.3.121806.151534.10.1146/annurev.pathmechdis.3.121806.15153418039131]Search in Google Scholar
[15. Lee DW, Gardner R, Porter D, et al. Current concepts in the diagnosis and management of cytokine release syndrome. Blood. 2014;124:188-195. doi: 10.1182/blood-2014-05-552729.10.1182/blood-2014-05-552729409368024876563]Search in Google Scholar
[16. Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271-280.e8. doi: 10.1016/j.cell.2020.02.052.10.1016/j.cell.2020.02.052710262732142651]Search in Google Scholar
[17. Driggin E, Madhavan M, Bikdeli B, et al. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic. J Am Coll Cardiol. 2020;75:2352-2371. doi: 10.1016/j.jacc.2020.03.031.10.1016/j.jacc.2020.03.031719885632201335]Search in Google Scholar
[18. Caforio A, Pankuweit S, Arbustini E, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34:2636-2648. doi: 10.1093/eurheartj/eht210.10.1093/eurheartj/eht21023824828]Search in Google Scholar
[19. Kociol R, Cooper L, Fang J, et al. Recognition and initial management of fulminant myocarditis: a scientific statement from the American Heart Association. Circulation. 2020;141:e69-e92. doi: 10.1161/CIR.0000000000000745.10.1161/CIR.000000000000074531902242]Search in Google Scholar
[20. Friedrich M, Sechtem U, Schulz-Menger J, et al. Cardiovascular magnetic resonance in myocarditis: a JACC White Paper. J Am Coll Cardiol. 2009;53:1475-1487. doi: 10.1016/j. jacc.2009.02.007.]Search in Google Scholar
[21. Sala S, Peretto G, Gramegna M, et al. Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection. Eur Heart J. 2020;41:1861-1862. doi: 10.1093/eurheartj/ehaa286.10.1093/eurheartj/ehaa286718433932267502]Search in Google Scholar
[22. Schiavone M, Gobbi G, Biondi-Zoccai G, et al. Acute Coronary Syndromes and Covid-19: Exploring the Uncertainties. J Clin Med. 2020;9:1683. doi: 10.3390/jcm9061683.10.3390/jcm9061683735653732498230]Search in Google Scholar
[23. Roffi M, Patrono C, Mueller C, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37:267-315. doi: 10.1093/eurheartj/ehv320.10.1093/eurheartj/ehv32026320110]Search in Google Scholar
[24. Thygesen K, Alpert J, Jaffe A, et al. Fourth universal definition of myocardial infarction (2018). Eur Heart J. 2019;40:226. doi: 10.1093/eurheartj/ehy856.10.1093/eurheartj/ehy85630649367]Search in Google Scholar
[25. Thygesen K, Mair J, Katus H, et al. Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J. 2010;31:2197-2204. doi: 10.1093/eurheartj/ehq251.10.1093/eurheartj/ehq25120685679]Search in Google Scholar
[26. Scholz K, Maier S, Maier L, et al. Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: Results from the German prospective, multicentre FITT-STEMI trial. Eur Heart J. 2018;39:1065-1074. doi: 10.1093/eurheartj/ehy004.10.1093/eurheartj/ehy004601891629452351]Search in Google Scholar
[27. Stefanini G, Azzolini E, Condorelli G. Critical organizational issues for cardiologists in the COVID-19 outbreak: A frontline experience from Milan, Italy. Circulation. 2020;141:1597-1599. doi: 10.1161/CIRCULATIONAHA.120.047070.10.1161/CIRCULATIONAHA.120.04707032207994]Search in Google Scholar
[28. Mahmud E, Dauerman H, Welt F, et al. Management of acute myocardial infarction during the COVID-19 pandemic. J Am Coll Cardiol. 2020;S0735-1097(20)35026-9. doi: 10.1016/j. jacc.2020.04.039.]Search in Google Scholar
[29. Leurent G, Langella B, Fougerou C, et al. Diagnostic contributions of cardiac magnetic resonance imaging in patients presenting with elevated troponin, acute chest pain syndrome and unobstructed coronary arteries. Arch Cardiovasc Dis. 2011;104:161-170. doi: 10.1016/j.acvd.2011.01.005.10.1016/j.acvd.2011.01.00521497305]Search in Google Scholar
[30. Clerkin K, Fried J, Raikhelkar J, et al. COVID-19 and cardiovascular disease. Circulation. 2020;141:1648-1655. doi: 10.1161/CIRCULATIONAHA.120.046941.10.1161/CIRCULATIONAHA.120.04694132200663]Search in Google Scholar
[31. Cheng R, Leedy D. COVID-19 and acute myocardial injury: the heart of the matter or an innocent bystander? Heart. 2020;106:1122-1124. doi: 10.1136/heartjnl-2020-317025.10.1136/heartjnl-2020-317025721109632354799]Search in Google Scholar
[32. Zeng JH, Liu YX, Yuan J, et al. First case of COVID-19 infection with fulminant myocarditis complication: case report and insights. Infection. 2020;1-5. doi: 10.1007/s15010-020-01424-5.10.1007/s15010-020-01424-5714607232277408]Search in Google Scholar